Briefing Detail Page
Health Care After the Supreme Court Decision: What's Next?
Monday, July 09, 2012
The Supreme Court has ruled on the constitutionality of the health reform law. Now it remains for stakeholders, policymakers, analysts and taxpayers to take it from here. Shifts in health care delivery towards more coordinated care to improve quality and efficiency are already taking place in the public and private sector. But many provisions in the law require specific actions to be taken and deadlines to be met by states, providers and others in order to implement various aspects of health reform scheduled to take effect in January, 2014.
How many states will be ready to open the doors of their health insurance exchanges on schedule? Is the federal government prepared to administer such exchanges in states that are not building their own? Will information systems be ready to determine eligibility for Medicaid or subsidized health insurance? What about the movement between the two as consumers' incomes vary across the year? Will some states continue to slow implementation efforts until after the November national elections?
What does the court's ruling mean for those without health insurance? Will states that choose to participate in the Medicaid expansion be ready to cover nearly all non-disabled adults under age 65 with household incomes at or below 133 percent of the federal poverty level as of January, 2014? Will some states likely choose not to participate in the expansion now that the court has removed the most severe penalty for not doing so?
Panelists were: Sheila Burke, Harvard University; Christopher Jennings, Jennings Policy Strategies; MaryBeth Musumeci, Kaiser Family Foundation; and Joshua Sharfstein, Maryland Department of Health and Mental Hygiene. Diane Rowland of Kaiser and Ed Howard of the Alliance co-moderated.
Ed Howard, Alliance for Health Reform , Moderator
Diane Rowland, Kaiser Family Foundation, Moderator
MaryBeth Musumeci , Kaiser Commission on Medicaid and the Uninsured, Speaker
Joshua Sharfstein , Maryland Department of Health and Mental Hygiene , Speaker
Sheila Burke , Kennedy School of Government at Harvard University, Speaker
Chris Jennings , Jennings Policy Strategies, Speaker
(Click on the camera icon to see a video of the speaker's presentation.)
|Event Summary and/or Webcast and Podcast|
Full Webcast/Podcast: Health Care After the Supreme Court Decision: What's Next?
|The full webcast and podcast for this briefing, as well as videos of individual speakers' presentations, are provided by Kaiser Family Foundation.
MaryBeth Musumeci's Presentation (Adobe Acrobat PDF), 7/9/2012
Joshua Sharfstein's Presentation (Adobe Acrobat PDF), 7/9/2012
(If you want to download one or more slides from these presentations, contact us at info@allhealth or click here for instructions.)
Supreme Court Decision on the Health Reform Law: Selected Experts and Resources (Adobe Acrobat PDF), Alliance for Health Reform, 6/27/2012
Materials List (Adobe Acrobat PDF), , 7/9/2012
Source List (Adobe Acrobat PDF), , 7/9/2012
|Offsite Materials (briefing documents saved on other websites)|
We lost on health care. But the constitution won., Washington Post, Outlook, 7/1/2012
- Barnett, Randy
Hail to the Chief (John Roberts, That Is): Thoughts on the Legislative Implications of Today’s Ruling., Brookings, 6/28/2012
- Binder, Sarah
The Individual Mandate: How Sweeping?, Kaiser Family Foundation, 3/21/2012
- Cox, Cynthia and Larry Levitt
Establishing Health Insurance Exchanges: An Overview of State Efforts, Kaiser Family Foundation, 7/1/2012
Obamacare Silver Linings: A Limited Victory for Limited Government, The Heritage Foundation, 6/28/2012
- Gaziano, Todd
Health Insurance Market Reforms: Guaranteed Issue (Adobe Acrobat PDF),Kaiser Family Foundation, 6/1/2012
Health Insurance Market Reforms: Rate Restrictions (Adobe Acrobat PDF),Kaiser Family Foundation, 6/1/2012
Supreme Court Lets Health Law Largely Stand, New York Times, 6/28/2012
- Liptak, Adam and John Cushman Jr.
For Health Sector: Forward, March, The Wall Street Journal, 6/29/2012
- Mathews, Anna W
A Guide to the Supreme Court’s Affordable Care Act Decision (Adobe Acrobat PDF),Kaiser Family Foundation, 7/1/2012
- Musumeci, MaryBeth
The Supreme Court’s Medicaid Ruling: ‘A Shift In Kind, Not Merely Degree’, Health Affairs Blog, 6/28/2012
- Rosenbaum, Sara
Decision Time for States on the Affordable Care Act.” , Health Affairs Blog, 7/2/2012
- Weil, Alan
ACA Implementation-Monitoring and Tracking: Maryland Site Visit Report (Adobe Acrobat PDF),The Urban Institute, 3/1/2012
- Blumberg, Linda
A Mid-Year State Medicaid Budget Update for FY 2012 & A Look Forward to FY 2013, The Kaiser Commission on Medicaid and Uninsured, 2/1/2012
What Supreme Court health care ruling means to business, Post Tribune, 6/28/2012
- Knowles, Francine, Monifa Thomas, and Sandra Guy
National Federation of Independent Business et al. v. Sebelius, Secretary of Health and Human Services, et al (Adobe Acrobat PDF),The Supreme Court of the United States, 6/28/2012
- Opinion of the Supreme Court of the United States
Where States Stand on Implementing Health Care Law, Associated Press, 6/28/2012
Toolkit on Connection Between Health and Housing
A new Alliance toolkit, “The Connection between Health and Housing: The Evidence and Policy Landscape,” provides a detailed look into federal, state and local initiatives, as well as cost implications for health and housing programs.
Attempts to tie health and housing policy are gaining momentum, amid evidence that housing, a social determinant of health, is an important factor in the health status of various populations. More than 610,000 people experience homelessness in the U.S., and over 250,000 individuals within that population have a severe mental illness or a chronic substance use disorder, according to the Department of Housing and Urban Development.
Toolkit on Biosimilars
The Alliance for Health Reform has released a new toolkit, “Biosimilars: Unpacking Complex Issues.”
The Affordable Care Act created an expedited licensure pathway for biosimilars, and, in March 2015, the U.S. approved the first biosimilar, leaving policy makers, regulators, providers and stakeholders to grapple with regulatory and financial questions.
Biosimilars are similar – but not identical – to biologic drugs, and cost less. Unlike traditional pharmaceuticals, biologic drugs are derived from living organisms and tissues, making them more complex and expensive to produce.